1. Nasr M R , El-Zammar O . Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions[J]. The American Journal of Dermatopathology, 2008, 30(2):117-122.
2. Hightower E, Cabanillas M E, Fuller G N, et al. Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas[J]. Pituitary, 2012, 15(4):556-561.
3. 中華醫(yī)學(xué)會(huì).《臨床技術(shù)操作規(guī)范·病理學(xué)分冊》.人民軍醫(yī)出版社,2004.